← boothcheck

CNC vs UNM stock comparison

CENTENE CORPORATION vs Unum Group, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

No growth column exists here, but the trajectories are legible anyway: Unum's disability-and-group-life book earns a steady 5.9% net margin priced at 19.5 times, while Centene's Medicaid book runs at a loss, negative 3.3% net, and trades on recovery hope rather than earnings. The stability gap shows in returns, 7.2% on equity against negative 30%. Unum pays a 2% dividend; Centene retains its float. Two insurers under one sector tag whose risks barely overlap: Unum's is actuarial, long-tail claims priced years ago; Centene's is political, state rate-setting cycles. The market currently trusts the actuarial tables and not the statehouses, and the prices say by how much.

Comparison updated 2026-07-10.

CNC vs UNM: the numbers

MetricCNCUNM
Price$65.73$90.06
Market cap$32.6B$14.8B
SectorManaged CareManaged Care
StageGrowthMature
P/E19.5
P/B1.511.36
P/S0.161.11
Revenue growth+17.4%+4.4%
Gross margin11.3%
Operating margin3.7%
Net margin-3.3%5.9%
Return on equity-30.0%7.2%
Return on assets-7.9%1.3%
Return on invested capital-14.1%
FCF yield21.8%3.6%
Dividend yield1.9%
Debt / equity0.760.35
Current ratio1.12
Altman Z (solvency)3.090.69
Piotroski F (quality)6 / 99 / 9
Full CNC report → Full UNM report →
Get boothcheck's read on CNC and UNM, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.